Ambrx Biopharma Inc (AMAM) - News Archive

Showing 3 of 3 results.

Ambrx Biopharma Shareholders Approve Merger Agreement with Johnson & Johnson, Solidify Position in NASDAQ Biotechnology Index

DateAmbrx Biopharma, Inc., (NASDAQ: AMAM), made a significant announcement today as its shareholders unanimously approved the proposal to adopt the merger agreement entered into between the Company and Johnson & Johnson...

Mar 6, 2024 • Biotechnology & Pharmaceuticals Industry Stock Market Announcement

Johnson & Johnson to Acquire Ambrx Biopharma, Revolutionizing Cancer Treatment with Next-Generation Antibody Drug Conjugates

Johnson & Johnson s Acquisition of Ambrx Biopharma to Revolutionize Cancer TreatmentNew Brunswick, N.J. - Johnson & Johnson, a leading pharmaceutical company, made a significant announcement today that it has inked a de...

Jan 8, 2024 • Biotechnology & Pharmaceuticals Industry Merger and Acquisition NASDAQ

Ambrx Biopharma, Inc. Joins NASDAQ Biotechnology Index, Signaling Growth Prospects for Shareholders

Ambrx Biopharma, Inc. To Join NASDAQ Biotechnology Index, Signaling Potential Growth for ShareholdersSAN DIEGO, Dec. 14, 2023 - Ambrx Biopharma, Inc. (NASDAQ: AMAM), a leading biotechnology company, announced today its...

Dec 14, 2023 • Biotechnology & Pharmaceuticals Industry Stock Market Announcement